Exchange Traded Concepts’s Syndax Pharmaceuticals SNDX Stock Holding History

Exchange Traded Concepts’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,769	Closed	-$120K	–	1498
2025 Q1	$120K	Buy	9,769 +568	+6%	+$8.01K	﹤0.01%	1089
2024 Q4	$122K	Hold	9,201	–	–	﹤0.01%	1111
2024 Q3	$177K	Sell	9,201 -394	-4%	-$8.14K	﹤0.01%	1001
2024 Q2	$197K	Sell	9,595 -2,985	-24%	-$62.5K	0.01%	878
2024 Q1	$299K	Buy	12,580 +4,504	+56%	+$100K	0.01%	796
2023 Q4	$175K	Buy	8,076 +2,048	+34%	+$31.5K	﹤0.01%	803
2023 Q3	$87.5K	Sell	6,028 -1,185	-16%	-$22.4K	﹤0.01%	946
2023 Q2	$151K	Buy	7,213 +6,355	+741%	+$132K	﹤0.01%	840
2023 Q1	$18.1K	Buy	+858	New	+$21.3K	﹤0.01%	976

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Exchange Traded Concepts's SNDX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Syndax Pharmaceuticals (SNDX) in Q2 2025, closing a stake of 9,769 shares — an estimated $120K sold.

Exchange Traded Concepts first reported a position in SNDX in Q1 2023 and held it in 9 quarters. The position peaked at $299K in Q1 2024. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

Exchange Traded Concepts reported no remaining Syndax Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Exchange Traded Concepts sold 9,769 Syndax Pharmaceuticals shares in Q2 2025, an estimated $120K.
Exchange Traded Concepts first reported a position in Syndax Pharmaceuticals in Q1 2023 and held it in 9 quarters.
Exchange Traded Concepts's Syndax Pharmaceuticals position peaked at $299K in Q1 2024.
216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.